AERIE PHARMACEUTICALS INC·4

Feb 8, 8:40 PM ET

Hollander David 4

4 · AERIE PHARMACEUTICALS INC · Filed Feb 8, 2022

Insider Transaction Report

Form 4
Period: 2022-02-04
Hollander David
Chief R&D Officer
Transactions
  • Tax Payment

    Common Stock

    2022-02-04$7.05/sh927$6,53530,749 total
Footnotes (1)
  • [F1]Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted Common Stock.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION